Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Mika Hamada"'
Autor:
Takuma Suzuki, Hiroaki Uchida, Tomoko Shibata, Yasuhiko Sasaki, Hitomi Ikeda, Mika Hamada-Uematsu, Ryota Hamasaki, Kosaku Okuda, Shigeru Yanagi, Hideaki Tahara
Publikováno v:
Molecular Therapy: Oncolytics, Vol 22, Iss , Pp 265-276 (2021)
Most oncolytic virotherapy has thus far employed viruses deficient in genes essential for replication in normal cells but not in cancer cells. Intra-tumoral injection of such viruses has resulted in clinically significant anti-tumor effects on the le
Externí odkaz:
https://doaj.org/article/ca4b98d0ead84764b3142f271e88d857
Autor:
Hirofumi Kanaizumi, Chihiro Higashi, Yumiko Tanaka, Mika Hamada, Wataru Shinzaki, Yukihiko Hashimoto, Yoshifumi Komoike
Publikováno v:
SAGE Open Medical Case Reports, Vol 7 (2019)
Breast carcinosarcoma is an extremely rare, clinically aggressive tumor, and no standard treatment has been established. We report about a 34-year-old woman presenting with a 2.5-cm-sized carcinosarcoma in her right breast. She presented to our hospi
Externí odkaz:
https://doaj.org/article/fe6bb93a15444bac961da9b9cba8aa1c
Publikováno v:
Nihon Nyugan Kenshin Gakkaishi (Journal of Japan Association of Breast Cancer Screening). 32:105-110
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::16177f410efdf9a4d37d1ee33eb8dbec
https://doi.org/10.3804/jjabcs.32.105
https://doi.org/10.3804/jjabcs.32.105
Autor:
Ryota Hamasaki, Shigeru Yanagi, Yasuhiko Sasaki, Hiroaki Uchida, Hitomi Ikeda, Tomoko Shibata, Takuma Suzuki, Kosaku Okuda, Mika Hamada-Uematsu, Hideaki Tahara
Publikováno v:
Molecular Therapy: Oncolytics, Vol 22, Iss, Pp 265-276 (2021)
Molecular Therapy Oncolytics
Molecular Therapy Oncolytics
Most oncolytic virotherapy has thus far employed viruses deficient in genes essential for replication in normal cells but not in cancer cells. Intra-tumoral injection of such viruses has resulted in clinically significant anti-tumor effects on the le
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f42b10b6e9037518b632599e0eb50735
https://doi.org/10.1016/j.omto.2021.08.002
https://doi.org/10.1016/j.omto.2021.08.002
Publikováno v:
American Journal of Medical Case Reports. 9:331-334
The patient was a 72-year-old woman who developed headache, fever, dyspnea, and taste disorder over a three-day period. A COVID-19 polymerase chain reaction (PCR) test was positive. As she was elderly and required oxygen supplementation, and was ther
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ed13d1d22ca62634f0f4f89d709a1e42
https://doi.org/10.12691/ajmcr-9-6-7
https://doi.org/10.12691/ajmcr-9-6-7
Autor:
Hideaki Tahara, Yasuhiko Sasaki, Miki Yamaguchi, Tomoko Shibata, Ryota Hamasaki, Hiroaki Uchida, Masato Tanaka, Masaki Kojima, Hirofumi Hamada, Takuma Suzuki, Hitomi Ikeda, Yu Okubo, Kosaku Okuda, Mika Hamada-Uematsu
Publikováno v:
J Virol
Herpes simplex virus (HSV) is a promising tool for developing oncolytic virotherapy. We recently reported a platform for receptor-retargeted oncolytic HSVs that incorporates single-chain antibodies (scFvs) into envelope glycoprotein D (gD) to mediate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af5eb97c765d22cf5f72a87ed5b12cd3
https://doi.org/10.1128/jvi.01766-20
https://doi.org/10.1128/jvi.01766-20
Autor:
Yukihiko Hashimoto, Tatsuya Azumi, Hirofumi Kanaizumi, Yoshifumi Komoike, Mika Hamada, Wataru Shinzaki
Publikováno v:
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 78:926-930
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f69418d4cf36cb895c9e01162dc20c51
https://doi.org/10.3919/jjsa.78.926
https://doi.org/10.3919/jjsa.78.926
Autor:
Yumiko Tanaka, Mika Hamada, Wataru Shinzaki, Hirofumi Kanaizumi, Yoshifumi Komoike, Chihiro Higashi, Yukihiko Hashimoto
Publikováno v:
SAGE Open Medical Case Reports
SAGE Open Medical Case Reports, Vol 7 (2019)
SAGE Open Medical Case Reports, Vol 7 (2019)
Breast carcinosarcoma is an extremely rare, clinically aggressive tumor, and no standard treatment has been established. We report about a 34-year-old woman presenting with a 2.5-cm-sized carcinosarcoma in her right breast. She presented to our hospi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69ee22a142c1e059aecee88e961d3a86
http://europepmc.org/articles/PMC6552342
http://europepmc.org/articles/PMC6552342
Autor:
Yu Mizote, Yuichiro Doki, Shuji Takiguchi, Makoto Yamasaki, Hiroshi Miyata, Hideaki Tahara, Hisashi Wada, Masaki Mori, Mika Hamada-Uematsu, Keijiro Sugimura, Kiyokazu Nakajima, Koji Tanaka, Takashi Kanemura
Publikováno v:
Cancer Science
The programmed death-1/programmed death-1 ligands (PD-1/PD-L) pathway plays an important role in immunological tumor evasion. However, the clinical significance of the PD-L (L1 and L2) expression in esophageal cancer treated with chemotherapy has not
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1458f5c8b3887ae317a27523b8c22592
https://doi.org/10.1111/cas.12938
https://doi.org/10.1111/cas.12938
Autor:
Toshiya Houjou, Hirofumi Kanaizumi, Yoshifumi Komoike, Wataru Shinzaki, Yumiko Tanaka, Tatsuya Azumi, Chihiro Higashi, Mika Hamada, Hiroki Inui, Yukihiko Hashimoto
Publikováno v:
Oncology letters. 17(2)
Oestrogen receptor (ER)-positive, metachronous, contralateral breast cancer (MCBC) sometimes develops during or soon after completion of hormone therapy (HT), but it is uncertain whether it is HT-resistant. We examined the association between ER-posi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85072f6e03ac0bcf4e44c65a1d13a0a5
https://pubmed.ncbi.nlm.nih.gov/30675261
https://pubmed.ncbi.nlm.nih.gov/30675261